Ignite Creation Date:
2024-05-06 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 12:51 PM
Study NCT ID:
NCT03618381
Status:
RECRUITING
Last Update Posted:
2024-04-09
First Post:
2018-07-16
Brief Title:
EGFR806 CAR T Cell Immunotherapy for RecurrentRefractory Solid Tumors in Children and Young Adults
Sponsor:
Seattle Childrens Hospital
Organization:
Seattle Childrens Hospital
Organization Data
Organization:
Seattle Childrens Hospital
Class:
OTHER
Study ID:
STRIvE-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Seattle Childrens Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Colleen Annesley
Responsible Party Title:
Medical Director Seattle Childrens Therapeutics
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Seattle Childrens Hospital
Old Name:
None
Old Organization:
None